MTOR and schizophrenia: Notably, pharmacological treatment with antipsychotics leads to increased pathway activation in mouse and cell-based models of schizophrenia (e.g. [89, 94–99]), and in the latter study, the antipsychotic haloperidol also increased dendritic spine density in an mTOR-dependent manner.